A highly sensitive and selective diagnostic assay based on virus nanoparticles

Department of Chemical and Biological Engineering, Korea University, Anam-Dong 5-1, Seongbuk-Gu, Seoul 136-713, Republic of Korea.
Nature Nanotechnology (Impact Factor: 31.17). 03/2009; 4(4):259-264. DOI: 10.1038/nnano.2009.38

ABSTRACT Early detection of the protein marker troponin I in patients with a higher risk of acute myocardial infarction1, 2, 3, 4, 5 can reduce the risk of death from heart attacks6, 7, 8, 9, 10. Most troponin assays are currently based on the conventional enzyme linked immunosorbent assay and have detection limits in the nano- and picomolar range11. Here, we show that by combining viral nanoparticles, which are engineered to have dual affinity for troponin antibodies and nickel, with three-dimensional nanostructures including nickel nanohairs, we can detect troponin levels in human serum samples that are six to seven orders of magnitude lower than those detectable using conventional enzyme linked immunosorbent assays11, 12, 13, 14, 15, 16. The viral nanoparticle helps to orient the antibodies for maximum capture of the troponin markers. High densities of antibodies on the surfaces of the nanoparticles and nanohairs lead to greater binding of the troponin markers, which significantly enhances detection sensitivities. The nickel nanohairs are re-useable and can reproducibly differentiate healthy serum from unhealthy ones. We expect other viral nanoparticles to form similar highly sensitive diagnostic assays for a variety of other protein markers.

  • Source
    07/2011; , ISBN: 978-953-307-443-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Traditional protein assays based on the recognition of a target molecule by signal probe in a 1:1 stoichiometric ratio are limitated in sensitivity because one target molecule causes the production of a single signal probe only. We report on a novel approach for the determination of angiogenin (Ang). It is based on the cleavage of the Nb.Bsm I (nicking endonucleases) and an associated signal amplification technology using Au nanoparticles (AuNPs) as labels. The signal is amplified via Ang-aptamer recognition and after cleavage of the Nb.Bsm I, upon which one Ang can produce several chemiluminescent signal probes based on AuNPs. This results in a significant increase in the limit of detection of Ang (0.2pmol L−1). The method also is highly selective. Ang was determined in serum samples, and the results confirmed the reliability and practicality of the protocol. FigureA novel approach for the determination of angiogenin (Ang) was developed based on the cleavage of the Nb.Bsm I and an associated signal amplification technology using Au nanoparticles (AuNPs) as labels. This results in a significant increase in the limit of detection of Ang (0.2pmol L−1) KeywordsNb.BsmI–Chemiluminescence–Angiogenin–Signal amplification–Au nanoparticles
    Microchimica Acta 174(3):375-382. · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is still in high demand to develop extremely sensitive and accurate clinical tools for biomarkers of interest for early diagnosis and monitoring of diseases. In this report, we present a highly sensitive and compatible gold nanoparticle (AuNP)-based fluorescence activatable probe for sensing ultra-low levels of prostate-specific antigen (PSA) in patient serum samples. The limit of detection of the newly-developed probe for PSA was pushed down to 0.032 pg/mL, which is more than two orders of magnitude lower than that of the conventional fluorescence probe. The ultrahigh sensitivity of this probe was attributed to the high loading efficiency of the dyes on AuNP surfaces and high fluorescence quenching-unquenching abilities of the dye-AuNP pairs. The efficiency and robustness of this probe was investigated in patient serum samples, demonstrating the great potential of this probe in real-world applications.
    ACS Nano 05/2013; · 12.03 Impact Factor


Available from
Sep 20, 2014